CHI Logo
Shop
Checkout
Header Graphic
February 4, 2012
| Insight Pharma Reports > Therapeutic Pipelines And Disease Markets

Therapeutic Pipelines & Disease Markets


The PI3K/Akt/mTOR Pathway
November 2011
Table of Contents | Tables and Figures | Executive Summary


New Trends in Preventive and Therapeutic Vaccines
October 2011
Table of Contents | Tables and Figures | Executive Summary


Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Table of Contents | Tables and Figures | Executive Summary


Kinase-Targeted Therapeutics
August 2011
Table of Contents | Tables and Figures | Executive Summary
Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis
July 2011
Table of Contents | Tables and Figures
Monoclonal Antibodies Pipeline
March 2011
Table of Contents | Tables and Figures


The Antiviral Pipeline: HIV, HCV, and Influenza
November 2010
Table of Contents | Tables and Figures


RNAi Therapeutics
October 2010
Table of Contents | Tables and Figures | Executive Summary


Nuclear Receptors: The Pipeline Outlook
September 2010
Table of Contents | Tables and Figures | Executive Summary


Diabetes Pipeline: Intense Activity to Meet Unmet Need
September 2010
Table of Contents | Tables and Figures


Drug Repositioning
July 2010
Table of Contents | Tables and Figures | Executive Summary


Epigenetic Drug & Diagnostic Pipelines
June 2010
Table of Contents | Tables and Figures | Executive Summary


Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine
April 2010
Table of Contents | Tables and Figures | Executive Summary


Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
January 2010
Table of Contents | Tables and Figures | Executive Summary


Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
December 2009
Table of Contents | Tables and Figures | Executive Summary


Immunotherapies and Vaccines for Nontraditional Indications
October 2009
Table of Contents | Tables and Figures | Executive Summary


Ion Channel Modulator Pipelines
September 2009
Table of Contents | Tables and Figures | Executive Summary
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
August 2009
Table of Contents | Tables and Figures | Executive Summary


Protease Inhibitors: Innovation Drives Drug Pipeline
February 2009
Table of Contents | Tables and Figures | Executive Summary
Kinase Therapeutics Insight Update 2 (August 2008 - September 2008)
October 2008
Immunotherapies and Vaccines for Cancer and Infectious Diseases
October 2008
Table of Contents | Tables and Figures | Executive Summary


GPCRs: Dawn of a New Era?
October 2008
Table of Contents | Tables and Figures | Executive Summary


Obesity Drug Pipeline: Developing Therapies for a Complex Disease
September 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutics Insight Update 1 (April 2008 - July 2008)
August 2008
Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
Table of Contents | Tables and Figures | Executive Summary

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008
Table of Contents | Tables and Figures | Executive Summary

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Table of Contents | Tables and Figures | Executive Summary

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Table of Contents | Tables and Figures | Executive Summary

Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Table of Contents | Tables and Figures | Executive Summary

Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Oncogenomics: The Future of Cancer Cure
January 2006
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

RNAi Therapeutics: Challenges in Drug Development and Delivery
November 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Hematological Cancer Therapeutics: Pipelines and Competition
October 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Table of Contents | Tables and Figures | Executive Summary

Inflammatory Disease Therapeutics: Pipelines
June 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
March 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Metabolic Syndrome: Pipeline Analysis/Forecast
January 2005
Table of Contents | Tables and Figures | Survey Questions | Executive Summary

Cambridge Healthtech Institute

Footer Image
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com